Vice versa, inhibition of the gp130/STAT3 signaling at different levels re-sensitized otherwise resistant rectal cancer cells to CRT in our cell culture systems as well as in our in vivo xenograft tumor model. This evidence concerns the gene STAT3 and rectal cancer.